Multi-national, randomized, controlled adaptive Phase III design for vilobelimab in ulcerative pyoderma gangrenosum Trial size to be adapted upon interim analysis with planned total patient number. | January 5, 2023
The structure of the residency, which involves 3-month–long rotations at rural clinics in Mississippi, is designed to address the shortage of rural-based dermatologists in the United States.